Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferumoxytol vs Oral Iron in Non-Dialysis CKD Anemia
NCT00255424Phase 3Completed
- Sponsor
- AMAG Pharmaceuticals, Inc.
- Start
- May 2004
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ferumoxytol in anemia (2 arms), sponsored by AMAG Pharmaceuticals, Inc. Primary endpoint: Mean change in hemoglobin from baseline at Day 35. Started May 2004; status: completed.
02
Drugs
ferumoxytol
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00255424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00255424.